SCHEMBL13243602

SCHEMBL13243602

CC(C)CC1(C(=O)NCc2cc(CF)cc(C(F)(F)F)c2)CCN(Cc2ccc3c(c2)OCO3)CC1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.46
KDM4E B2RXH2 3/20 0.46
TDP1 Q9NUW8 2/20 0.46
HTT P42858 1/20 0.46
POLB P06746 1/20 0.45
MME P08473 1/20 0.45
TACR1 P25103 1/20 0.43
MCHR1 Q99705 4/20 0.43
PPARG P37231 1/20 0.43
CCR2 P41597 2/20 0.41
LMNA P02545 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
TSHR P16473 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA7 P43166 1/20 0.41
CA9 Q16790 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
HPGD P15428 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3033257 0.95 ALDH1A1 (0.48) ALDH1A1KDM4ETDP1HTTPOLB
SCHEMBL3033033 0.92 CYP3A4 (0.49) ALDH1A1KDM4ETDP1HTTPOLB
SCHEMBL3034263 0.89 PPARG (0.53) ALDH1A1KDM4ETDP1HTTPOLB
SCHEMBL3029012 0.84 LMNA (0.53) ALDH1A1KDM4ETDP1HTTPOLB
SCHEMBL13243604 0.83 UBE2M (0.49) ALDH1A1KDM4ETDP1TACR1PPARG
SCHEMBL14222033 0.83 MAPT (0.48) KDM4EPOLBCCR2TSHR
SCHEMBL14222527 0.83 CCR2 (0.47) CCR2
SCHEMBL3028682 0.82 MCHR1 (0.49) ALDH1A1KDM4ETDP1HTTPOLB
SCHEMBL3028685 0.82 MCHR1 (0.49) ALDH1A1KDM4ETDP1HTTPOLB
SCHEMBL3030479 0.82 MCHR1 (0.49) ALDH1A1KDM4ETDP1HTTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100210633-A1 CARBOXAMIDE COMPOUNDS AND THEIR USE EPIX DELAWARE, INC. (US) 2010-08-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100210633-A1 CARBOXAMIDE COMPOUNDS AND THEIR USE CCR2, CCR1, CCR5 ALDH1A1 1247/4885KDM4E 3492/4885TDP1 3840/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.